Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15–3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions-Reference-Cited by-同舟云学术

Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15–3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions

Published:2004-12 Issue:6 Volume:126 Page:1757-1763
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Porcel José Manuel,Vives Manuel,Esquerda Aureli,Salud Antonieta,Pérez Begoña,Rodríguez-Panadero Francisco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference25 articles.

1. BTS guidelines for the investigation of a unilateral pleural effusion in adults;Maskell;Thorax,2003

2. Medical thoracoscopy;Loddenkemper,2003

3. Clinical evaluation of CYFRA 21–1 in malignant fluids;Satoh;Oncology,1995

4. Diagnostic value of CA 72–4, carcinoembryonic antigen, CA 15–3, and CA 19–9 assay in pleural fluid: a study of 207 patients;Villena;Cancer,1996

5. CEA, CA 15–3 and CYFRA 21–1 in serum and pleural fluid of patients with pleural effusions;Romero;Eur Respir J,1996

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor markers determination in malignant pleural effusion: pearls and pitfalls;Clinical Chemistry and Laboratory Medicine (CCLM);2024-08-16

2. Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma;Discover Oncology;2024-06-24

3. FAM83A: A Prospective Diagnostic Biomarker with Immunological Relevance in Lung Adenocarcinoma- Associated Malignant Pleural Effusion;2024-06-07

4. Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology;Medical Journal of Babylon;2024-04

5. Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion;The Korean Journal of Internal Medicine;2024-03-01